Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
neurodegenerative diseases
gene therapy |
| gptkbp:foundedIn |
2017
|
| gptkbp:founder |
gptkb:Asa_Abeliovich
|
| gptkbp:headquartersLocation |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
Prevail Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:PR001
gptkb:PR006 |
| gptkbp:parentCompany |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:website |
https://www.prevailtherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:礼来
|
| gptkbp:bfsLayer |
5
|